UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm

Neonatology (Basel, Switzerland), 2017-01, Vol.112 (1), p.87-91

2017

Volltextzugriff (PDF)

Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

The American journal of cardiology, 2008, Vol.102 (6), p.733-737

2008

Volltextzugriff (PDF)

Renin–angiotensin-system blockade in the prevention of diabetes

Diabetes research and clinical practice, 2007-05, Vol.76 (3), p.S13-S21

Ostergren, Jan

2007

Volltextzugriff (PDF)

Associations Between Crowding and Ten-Day Mortality Among Patients Allocated Lower Triage Acuity Levels Without Need of Acute Hospital Care on Departure From the Emergency Department

Annals of emergency medicine, 2019-09, Vol.74 (3), p.345-356

2019

Volltextzugriff (PDF)

Predictors of mortality and morbidity in patients with chronic heart failure

European heart journal, 2006-01, Vol.27 (1), p.65-75

2006

Volltextzugriff (PDF)

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

The American heart journal, 2011-11, Vol.162 (5), p.900-906

2011

Volltextzugriff (PDF)

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

The Lancet (British edition), 2005-09, Vol.366 (9489), p.895-906

2005

Volltextzugriff (PDF)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Volltextzugriff (PDF)

Interruptions in emergency department work: an observational and interview study

BMJ quality & safety, 2013-08, Vol.22 (8), p.656-663

2013

Volltextzugriff (PDF)

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial

Journal of hypertension, 2001-06, Vol.19 (6), p.1139-1147

2001

Volltextzugriff (PDF)

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

European heart journal, 2008-06, Vol.29 (11), p.1377-1385

2008

Volltextzugriff (PDF)

Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation

Scandinavian cardiovascular journal : SCJ, 2023-12, Vol.57 (1), p.2236341-2236341

2023

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.767-771

2003

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.772-776

2003

Volltextzugriff (PDF)

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.777-781

2003

Volltextzugriff (PDF)

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

The Lancet (British edition), 2003-09, Vol.362 (9386), p.759-766

2003

Volltextzugriff (PDF)

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES

Journal of the American College of Cardiology, 2007-02, Vol.49 (6), p.687-694

2007

Volltextzugriff (PDF)

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

The Lancet (British edition), 2003-04, Vol.361 (9364), p.1149-1158

2003

Volltextzugriff (PDF)

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

European heart journal, 2008-11, Vol.29 (21), p.2641-2650

2008

Volltextzugriff (PDF)

Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation (Vol 57, 2236341, 2023)

SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2024-12, Vol.58 (1)

2024

Volltextzugriff (PDF)

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

European heart journal, 2013-07, Vol.34 (28), p.2159-2219

2013

Volltextzugriff (PDF)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

European heart journal, 2013, Vol.34 (39), p.3035

2013

Volltextzugriff (PDF)

Physicians’ and nurses’ perceptions of patient safety risks in the emergency department

International emergency nursing, 2017-07, Vol.33, p.14-19

2017

Volltextzugriff (PDF)

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

European heart journal, 2011-11, Vol.32 (22), p.2851-2906

2011

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEuropean Journal Of Heart Failure

ThemaPeripheral Vascular Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(83)
Life Sciences & Biomedicine
(80)
Science & Technology
(80)
Medicin Och Hälsovetenskap
(68)
Male
(57)
Female
(54)
Middle Aged
(44)
Biological And Medical Sciences
(40)
Medical Sciences
(40)
Aged
(39)
Adult
(38)
Cardiac & Cardiovascular Systems
(26)
Cardiovascular System & Cardiology
(26)
Risk Factors
(26)
Cardiology. Vascular System
(20)
Heart
(20)
Heart Failure
(18)
Sweden
(17)
Antihypertensive Agents - Therapeutic Use
(16)
Blood Pressure
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm

Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction

Renin–angiotensin-system blockade in the prevention of diabetes

Associations Between Crowding and Ten-Day Mortality Among Patients Allocated Lower Triage Acuity Levels Without Need of Acute Hospital Care on Departure From the Emergency Department

Predictors of mortality and morbidity in patients with chronic heart failure

Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure

Interruptions in emergency department work: an observational and interview study

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme

Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation (Vol 57, 2236341, 2023)

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Physicians’ and nurses’ perceptions of patient safety risks in the emergency department

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

Aktive Filter

Suchergebnisse filtern